Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Jul 26, 2026
Chardan réduit l'objectif de prix d'Iovance (IOVA), maintient sa recommandation à l'achat
Chardan Cuts Iovance (IOVA) Price Target, Keeps Buy Rating
While IOVA's Q1 revenue growth is impressive, the panelists have mixed views on its sustainability and profitability. The price target …
Canaccord Maintient une Recommandation d’Achat sur Taysha (TSHA) Après les Points Forts du T1
Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights
The panelists have mixed views on TSHA's potential. While some see promise in the FDA alignment and the addressable market, …
H.C. Wainwright et Wells Fargo relèvent les objectifs de cours de MannKind (MNKD)
H.C. Wainwright and Wells Fargo Lift MannKind (MNKD) Price Targets
The panelists agree that MannKind's (MNKD) valuation hinges on the success of its royalty streams, particularly from Tyvaso DPI, and …
1 Un analyste de Wall Street pense que CRISPR Therapeutics pourrait plus que doubler. Devriez-vous acheter l'action à tout prix ?
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist?
CRISPR Therapeutics' stock performance is driven by optimism around CTX611 and oncology candidates, but faces significant risks including complex manufacturing, …
Geron (GERN) est-elle l'une des meilleures actions américaines à moins de 5 $ à acheter ?
Is Geron (GERN) One of the Best US Stocks Under $5 to Buy?
Geron's (GERN) commercial success hinges on RYTELO's adoption curve and potential label expansion. While Q1 2026 revenue of $51.8M shows …
Bénéfices du premier trimestre de Korea Electric Power en hausse
Korea Electric Power Q1 Earnings Rise
The panel consensus is bearish, with all participants expressing concerns about KEP's earnings growth, margin compression, and significant debt servicing …
SK Innovation annonce un bénéfice au T1
SK Innovation Reports Profit In Q1
SK Innovation's Q1 results show a dramatic turnaround, but sustainability is uncertain due to the lack of segment breakdown and …
12 mois à partir de maintenant, souhaiterez-vous avoir acheté Bloom Energy aujourd'hui ?
12 Months From Now, Will You Wish You Bought Bloom Energy Today?
The panel consensus is bearish on Bloom Energy, citing its high valuation, reliance on natural gas, and execution risks in …
1 Action Partage à Acheter Avant Qu'elle Ne Rejoigne Nvidia, Alphabet, Apple et Microsoft dans le Club des 3 000 Milliards de Dollars
1 Unstoppable Stock to Buy Before It Joins Nvidia, Alphabet, Apple, and Microsoft in the $3 Trillion Club
The panel is divided on TSMC's potential to reach a $3T market cap by 2028. While some argue its dominance …
La croissance des revenus de Plug Power s'accélère. Est-il temps d'acheter l'action d'hydrogène ?
Plug Power's Revenue Growth is Accelerating. Is it Time to Buy the Hydrogen Stock?
The panel consensus is bearish on Plug Power, citing persistent losses, high cash burn, dilution risks, and the precarious nature …
Ceconomy : perte au T2 plus importante, l'EBIT ajusté en hausse ; confirme les perspectives pour l'exercice 2026
Ceconomy Q2 Loss Widens, Adj. EBIT Rises; Backs FY26 Outlook
The panel consensus is bearish, with concerns about Ceconomy's cash burn, working capital, and the sustainability of its earnings growth. …
Est-ce que l'action DraftKings est un achat grâce à son potentiel de super-application ?
Is DraftKings Stock a Buy on Super-App Potential?
The panel consensus is bearish on DraftKings (DKNG), with concerns about rising customer acquisition costs, regulatory risks, and potential margin …